19th Congress of ECCO

Pau Sendra Rumbeu, digestólogo del Hospital Universitario Son Espases, participó junto con otros centros, con la comunicación titulada "Short and long-term effectiveness and safety of ustekinumab in Ulcerative Colitis in real life: the ULISES study".

Vanesa Royo, digestóloga del Hospital Universitario Son Espases, participó junto con otros centros, con los pósteres titulados:

• Faecal microbiota composition by shotgun metagenomic sequencing approach in a newly diagnosed cohort of inflammatory bowel disease patients: results from the IBDomics project.
• Novel biomarkers associated with inflammatory bowel disease.

Raul José Díaz Molina y Daniel Ginard, digestólogos del Hospital Universitario Son Espases; y Núria Rull Murillo, digestóloga del Hospital Universitario Son Llàtzer; participaron junto con otros centros, con el póster titulado: "Short-term real-world effectiveness and safety of granulocyte and monocyte adsorptive apheresis (GMA) in patients with inflammatory bowel disease: GRACE Study".

R.J. Díaz Molina, C. Comesaña Castellar, J. Crespi Rigo, C. Radu Tomsa, P. Quesada Bauzá, I. Porcel Corral, D. Ginard Vicens, digestólogos y digestólogas del Hospital Universitario Son Espases, participaron con el póster titulado "Descriptive observational pilot study about the use of Virtual Reality (VR) in patients with Inflammatory Bowel Disease (IBD) and biological treatment".

Daniel Ginard, digestólogo del Hospital Universitario Son Espases, participó junto con otros centros, con los pósteres titulados:

• Combination of granulocyte–monocyte apheresis and ustekinumab: multicentre and retrospective study.
• Variability in Mesalazine Management for Ulcerative Proctitis Include Doses, Route of Administration and Use of Fecal Calprotectin: Insights from Clinical Practice Across Spain Beyond Clinical Guidelines.
• Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU.
• Perceptions of patients with Inflammatory Bowel Disease and first degree relatives on prediction and prevention of disease.

Inma Ros-Vilamajo, reumatóloga del Hospital Universitario Son Llàtzer; y Núria Rull, digestóloga del Hospital Universitario Son Llàtzer, participaron junto con otros centros, con el póster titulado "Prevalence of undiagnosed inflammatory Bowel Disease in patients with spondyloarthritis: EISER Study".

Núria Rull, digestóloga del Hospital Universitario Son Llàtzer, participó junto con otros centros, con el póster titulado "Short-term real-world effectiveness and safety of granulocyte and monocyte adsorptive apheresis (GMA) in patients with inflammatory bowel disease: GRACE Study".

Silvia Patricia Ortega Moya, digestóloga del Hospital Comarcal d'Inca, participó junto con otros centros, con el póster titulado: "Impact of celiac disease on the outcome of Inflammatory Bowel Disease".

Eduardo Iyo, digestólogo del Hospital Comarcal de Inca, participó junto con otros centros, con los pósteres titulados:

• Persistence and safety of upadacitinib in Crohn’s disease and ulcerative colitis in real life: results from a Spanish nationwide study.
• Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study.

José Reyes, digestólogo del Hospital Comarcal de Inca, participó junto con otros centros, con el póster titulado "Long-term follow-up of the PROTDILAT study; LONG-PROTDILAT Prospective multicenter randomized comparative study of endoscopic treatment of strictures in Crohn's disease (CD): self-expandable metal stent (SEMS) vs endoscopic balloon dilatation (EBD)".

Libro de resúmenes.

[Fuente: Bibliosalut]

[Foto: European Crohn's and Colitis Organisation]